Pantoprazol Actavis (Pantoprazole Sodium)

Pantoprazole Sodium, the active ingredient in Pantoprazol Actavis, is a proton pump inhibitor presented as a unknown strength/unknown form for gastroenteral use. It reduces gastric acid secretion and is used to manage acid‑related disorders in adults and children. GNH USA supplies Pantoprazol Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Actavis is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and esophageal irritation. - Erosive esophagitis: promotes healing of erosive lesions in the esophagus. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare tumor. - Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and symptom relief. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Pantoprazol Actavis may cause a range of adverse reactions. The profile includes both frequently observed and less common events.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Acute interstitial nephritis: kidney inflammation. - Severe hypersensitivity reactions: rash, angioedema, anaphylaxis. - Osteoporosis‑related fractures: hip, wrist or vertebral. - Low magnesium (hypomagnesemia): may cause muscle cramps or arrhythmia. - Liver enzyme elevation: increased ALT/AST.

When prescribing Pantoprazol Actavis, clinicians should consider several safety aspects: - Renal impairment: dose adjustment may be required. - Hepatic impairment: monitor liver function tests. - Elderly patients: increased risk of fractures and infections. - Concomitant use with clopidogrel: assess bleeding risk. - Long‑term therapy: evaluate need for periodic reassessment. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Pantoprazol Actavis can affect the pharmacokinetics of several co‑administered medicines. Awareness 

Major Interactions (Avoid): - Warfarin: may increase INR . - Atorvastatin: increased exposure. - Methotrex . - Clopidogrel: reduced antiplatelet effect. -  

Moderate  g  

t  """"""""""""""""""""""""""""""""""""""""""""""""